In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by startups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic. Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list. Circadia […]
CEO Ryan explains how Cala Health is building bioelectronic medicine business
In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health. Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala […]
Study: PPE shortages persist nationwide
Shortages of personal protective equipment continue to plague hospitals and healthcare facilities across the United States, according to a study published this week in The Lancet. The study reports on data collected by GetUsPPE, a volunteer organization connecting healthcare providers with supplies of PPE during the COVID-19 pandemic and was authored by academics and volunteers […]
3M sues Florida company for alleged mask price-gouging
3M (NYSE:MMM) has sued a Florida company for allegedly trying to sell tens of millions of the company’s N95 respirators to the federal government at inflated prices. The lawsuit filed in the U.S. District Court for the Northern District of Florida alleges that Orlando-based Geftico LLC twice attempted to fraudulently sell the “likely nonexistent” respirators at […]
LivaNova adds Verily to depression study
LivaNova (NSDQ:LIVN) announced that it has added Google’s (NSDQ:GOOGL) Verily to its study of vagus nerve stimulation (VNS) therapy for difficult-to-treat depression (DTD). The Recover clinical will gather quantitative data on patient behavior using Verily’s technology and analytics. The data could help the researchers understand depressive episodes and the patient’s response to treatment. Study participants will […]
Verily, Santen do a JV for ophthalmological devices
Santen Pharmaceutical (OTC:SNPHY) and Verily, an Alphabet (NSDQ:GOOGL) company, announced that they are entering into a joint venture to focus on applying microelectronics and scalable digital technologies to ophthalmology. Osaka, Japan-based Santen and San Francisco-based Verily say they want to improve eye health globally. According to a news release, the joint venture is slated to combine […]
New 510(k) boosts iRhythm, Verily efforts for AFib screening
The latest 510(k) clearance for the Verily Study Watch will further the efforts of the Google sister company and iRhythm Technologies (NSDQ:IRTC) to improve atrial fibrillation treatment. Verily — a life science company under Alphabet (NSDQ:GOOGL) — recently received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. “We’ve worked carefully […]
FDA clears Verily Study Watch for additional capabilities
Verily, Google’s life science’s sister company under Alphabet (NSDQ:GOOGL), has received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. The FDA announcement, last updated Jan. 20, did not include additional information. The agency cleared ECG capabilities on the Study Watch in January 2019. Launched in April 2017, the Study […]
Verily hires former Tesla executive as CFO
Verily — Google’s life sciences sister company under Alphabet (NSDQ:GOOG) — has hired Tesla veteran Deepak Ahuja as its CFO, according to a report on CNBC. Ahuja previously served two stints as CFO at Tesla. He left Tesla in early 2019 and was serving as a senior advisor to Capricorn Investment Group, according to his LinkedIn […]
J&J to acquire remaining stake in Verb Surgical
Johnson & Johnson (NYSE:JNJ) announced today that it agreed to acquire the remaining stake in Verb Surgical, following a successful strategic collaboration with Alphabet (NSDQ:GOOGL) life sciences unit Verily. Verb Surgical’s robotics and data science capabilities were the driving force behind Johnson & Johnson’s decision to combine with the company as it seeks to advance medical interventions, making […]
Google to pay more than $2B for Fitbit
Fitbit (NYSE:FIT) today confirmed the rumor of an acquisition by Google parent Alphabet (NSDQ:GOOG), revealing that it accepted a $7.35-per-share cash offer worth about $2.1 billion. “More than 12 years ago, we set an audacious company vision – to make everyone in the world healthier. Today, I’m incredibly proud of what we’ve achieved towards reaching that goal. We […]
- 1
- 2
- 3
- …
- 14
- Next Page »
